Key result
In patients undergoing minimally invasive cardiac surgery with femoral artery cannulation, the incidence of intraoperative NIRS-diagnosed distal limb ischemia was 26.79%, with no patients requiring vascular surgery for intraoperative ischemia within 6 months.
Why the study?
Literature regarding the monitoring and consequences of distal limb ischemia due to femoral artery cannulation for minimally invasive cardiac surgery remains limited.
What is the incidence and clinical significance of NIRS-diagnosed distal limb ischemia in patients undergoing MICS with femoral artery cannulation?
Cohort (n=280)
Single-blind (rSO2 measurements blinded to clinical team)
No
What is the incidence and clinical significance of NIRS-diagnosed distal limb ischemia in patients undergoing MICS with femoral artery cannulation?
Intraoperative NIRS monitoring detects distal limb ischemia in up to 26.8% of MICS patients with femoral cannulation, but this does not translate to short- or long-term vascular sequelae requiring surgery.
NIRS detects variable distal limb ischemia rates in MICS femoral cannulation without sequelae; leaves open routine monitoring utility pending prospective trials.
Literature regarding monitoring and consequences of distal limb ischemia due to femoral artery cannulation for Minimally Invasive Cardiac Surgery (MICS) remains limited. The primary objective was to determine its incidence, defined as a ≥ 15% difference in regional Oxygen Saturation (rSO 2 ) lasting ≥ four consecutive minutes between the cannulated and non-cannulated limb. The secondary objectives included: determination of distal limb ischemia, defined as a Tissue Oxygenation Index (TOI) < 50% in the cannulated limb, identification of predictors for distal limb ischemia, determination of a possible association of NIRS-diagnosed ischemia with acute kidney injury, and the need for vascular surgery up to six months after cardiac surgery. A prospective, observational cohort study with blinded rSO 2 -measurements to prevent intraoperative clinical decision-making. A single-center, community-hospital, clinical study. All consecutive patients ≥ 18 years old, and scheduled for predefined MICS. Patients underwent MICS with bilateral calf muscle rSO 2 -measurements conducted by Near-Infrared Spectroscopy (NIRS). In total 75/280 patients (26.79%) experienced distal limb ischemia according to the primary objective, while 18/280 patients (6.42%) experienced distal limb ischemia according to the secondary objective. Multivariate logistic regression showed younger age to be an independent predictor for distal limb ischemia ( p = 0.003). None of the patients who suffered intraoperative ischemia required vascular surgery within the follow-up period. The incidence of NIRS-diagnosed ischemia varied from 6.4% to 26.8% depending on the used criteria. Short and long-term vascular sequelae, however, are limited and not intraoperative ischemia related. The added value of intraoperative distal limb NIRS monitoring for vascular reasons seems limited. Future research on femoral artery cannulation in MICS should shift focus to other outcome parameters such as acute kidney injury, postoperative pain or paresthesias.
No takes yet. Share an insight, caveat, or question.
Ceulemans et al. (2023) conducted a cohort in Minimally Invasive Cardiac Surgery (MICS) (n=280). Femoral artery cannulation was evaluated on Incidence of distal limb ischemia (defined as a ≥ 15% difference in regional Oxygen Saturation lasting ≥ 4 consecutive minutes between the cannulated and non-cannulated limb). In patients undergoing minimally invasive cardiac surgery with femoral artery cannulation, the incidence of intraoperative NIRS-diagnosed distal limb ischemia was 26.79%, with no patients requiring vascular surgery for intraoperative ischemia within 6 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: